Prelude Capital Management, LLC Cel Sci Corp Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.1 - $12.82 $217,260 - $392,292
-30,600 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.64 - $12.49 $233,784 - $382,194
30,600 New
30,600 $336,000
Q1 2020

May 15, 2020
SELL
$7.54 - $17.05 $4,524 - $10,230
-600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$6.71 - $9.55 $4,026 - $5,730
600 New
600 $5,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $33.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email